Lilly and the Lilly Foundation have each provided support to the Academic Model Providing Access to Healthcare (AMPATH), which has been working for 30 years in western Kenya to improve health for people with limited resources. Lilly’s product donations in support of AMPATH Kenya total $215 million – including $29 million in medicines in 2022 – and are helping people living with cancer, diabetes and mental health disorders. Since 2017, the Lilly Foundation has supported AMPATH’s Breast and Cervical Cancer Control Program, which has far surpassed its original targets for offering early screenings and connecting people with cancer care as appropriate. Most recently, Lilly and the Lilly Foundation provided support to AMPATH’s efforts to establish new health partnerships in Puebla, Mexico, and Tamale, Ghana, which have the potential to reach more than 14 million people by 2030. Lilly has committed support of more than $2.8 million to help establish AMPATH in Puebla. The Lilly Foundation awarded $600,000 for efforts to provide additional personnel in Ghana and $520,000 to support the IU Center for Global Health Equity as the coordinating secretariat of the global AMPATH Consortium of 15 academic health centers from around the world.